Tag: Immune Disorders
Weekly Dupilumab Beneficial in Eosinophilic Esophagitis
More patients receiving dupilumab have histologic remission, improvement in Dysphagia Symptom Questionnaire scores
MI Outcomes May Be Worse in Patients With Rheumatic IMID
MI outcomes poorer in Medicare beneficiaries with versus without rheumatic immune-mediated inflammatory disease
Incident Cardiovascular Disease Risk Up With Autoimmune Disease
Risk increased progressively with the number of autoimmune diseases present and with younger age
Guidelines Issued for Vaccination in Patients With Rheumatic, Musculoskeletal Diseases
Guidelines expand indications for some vaccines and provide guidance on medication management at time of vaccination
Fourth COVID-19 Vaccine Dose Safe for Immunocompromised
Local and systemic reactions reported less frequently after fourth dose versus dose 3 of primary vaccination series
Immunocompromised Hospitalized With COVID-19 Have Poor Outcomes
Immunocompromised patients have increased odds of ICU admission, in-hospital death, regardless of vaccination status
Azathioprine Discontinuation Up for Patients With CC Genotype
Patients with rs2814778-CC also have lower last leukocyte count and lower dosing; findings persist after adjustment for race
mRNA-1273 Induces Stronger Response Than BNT162b2 for Immunosuppressed
Findings seen in immunosuppressed patients with rheumatic and musculoskeletal diseases, solid organ transplant recipients
Recent Cancer May Increase Risk for Guillain-Barré Syndrome
Odds ratios for GBS were highest for cancers of lymphatic and hematopoietic tissue, respiratory tract, prostate, breast
Nintedanib Slows Decline in FVC in Autoimmune Disease-Linked ILD
Subgroup analysis performed for patients with autoimmune disease-related progressive fibrosing interstitial lung diseases